发明名称 |
USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE |
摘要 |
This invention is directed to the use of ranolazine to reduce the risk of adverse coronary events in a mammalian patient. Typically, the natriuretic peptide is associated with coronary disease, acute coronary syndrome, and/or diastolic dysfunction. Ranolazine may be administered to the patient as an intravenous solution or in an oral dose.
|
申请公布号 |
US2008233191(A1) |
申请公布日期 |
2008.09.25 |
申请号 |
US20080052381 |
申请日期 |
2008.03.20 |
申请人 |
BLACKBURN BRENT;JERLING MARCUS;WOLFF ANDREW |
发明人 |
BLACKBURN BRENT;JERLING MARCUS;WOLFF ANDREW |
分类号 |
A61K9/22;A61K31/495;A61P9/00 |
主分类号 |
A61K9/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|